Fatigue, Depression, and Insomnia: Evidence for a Symptom Cluster in Cancer

Seminars in Oncology Nursing

Volumn 23, Issue 2, 2007, Pages 127-135

  Donovan, Kristine A ^a   Jacobsen, Paul B ^a  

^a NONE

Author keywords

cancer; depression; fatigue; insomnia; Symptom cluster

Indexed keywords

ARTICLE; CLUSTER ANALYSIS; DEPRESSION; FATIGUE; HUMAN; INSOMNIA; NEOPLASM; PATHOPHYSIOLOGY;

CLUSTER ANALYSIS; DEPRESSION; FATIGUE; HUMANS; NEOPLASMS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 34248575047     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2007.01.004     Document Type: Article

References (70)

1. Dodd M.J., Miaskowski C., and Paul S.M. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28 (2001) 465-470
2. McNair D.M., Lorr M., and Doppleman L.F. Profile of Mood States Manual (1971), Educational and Industrial Testing Service, San Diego, CA
3. McCorkle R., and Young K. Development of a symptom distress scale. Cancer Nurs 1 (1978) 373-378
4. Beck A.T., Ward C.H., Mendelson M., et al. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 53-63
5. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychol Meas 1 (1977) 385-401
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
7. Buysse D.J., Reynolds III C.F., Monk T.H., et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psych Res 28 (1989) 193-213
8. Morin C.M. Insomnia: Psychological Assessment and Management (1993), The Guilford Press, New York
9. Savard M.H., Savard J., Simard S., et al. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncol 14 (2005) 429-441
10. American Sleep Disorders Association. The International Classification of Sleep Disorders. Diagnostic and Coding Manual (1997), American Sleep Disorders Association, Rochester, NY
11. Cella D., Peterman A., Passik S., et al. Progress toward guidelines for the management of fatigue. Oncology 12 (1998) 369-377
12. Smets E.M.A., Garssen B., Cull A., et al. Application of the Multidimensional Fatigue Inventory (MFI-20) in cancer patients receiving chemotherapy. Br J Cancer 73 (1996) 241-245
13. Stein K.D., Martin S.C., Hann D.M., et al. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6 (1998) 143-152
14. Lawrence D.P., Kupelnick B., Miller K., et al. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32 (2004) 40-50
15. Ahlberg K., Ekman T., Gaston-Johansson F., et al. Assessment and management of cancer-related fatigue in adults. Lancet 362 (2003) 640-650
16. Pirl W. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr 32 (2004) 32-39
17. Massie M.J. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32 (2004) 57-71
18. Savard J., and Morin M.C. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19 (2001) 895-908
19. Savard J., Simard S., Hervouet S., et al. Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncol 14 (2005) 147-156
20. Savard J., Simard S., Blanchet J., et al. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 24 (2001) 583-590
21. Andrykowski M.A., Curran S.L., and Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21 (1998) 1-18
22. Broeckel J.A., Jacobsen P.B., Horton J., et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16 (1998) 1689-1696
23. Carpenter J.S., and Andrykowski M.A. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 45 (1998) 5-13
24. Carpenter J.R., Elam J.L., Ridner S.H., et al. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31 (2004) 591-598
25. Fillion L., Gelinas C., Simard S., et al. Validation evidence for the French Canadian adaptation of the Multidimensional Fatigue Inventory as a measure of cancer-related fatigue. Cancer Nurs 26 (2003) 143-153
26. Hann D.M., Jacobsen P.B., Martin S.C., et al. Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer. Support Care Cancer 5 (1997) 44-52
27. Hwang S.S., Chang V.T., and Kasimis B.S. A comparison of three fatigue measures in veterans with cancer. Cancer Invest 21 (2003) 363-373
28. Mock V., Dow K.H., Meares C.J., et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 24 (1997) 991-1000
29. Okuyama T., Akechi T., Kugaya A., et al. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 8 (2000) 215-222
30. Redeker N.S., Lev E.L., and Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract 14 (2000) 275-290
31. Smets E.M.A., Visser M., Willems-Groot A.F., et al. Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer 78 (1998) 899-906
32. Smets E.M.A., Visser M., Willems-Groot A.F., et al. Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. Br J Cancer 78 (1998) 907-912
33. Stone P., Hardy J., Broadley K., et al. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer 79 (1999) 1479-1486
34. Stone P., Hardy J., Huddart R., et al. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 36 (2000) 1134-1141
35. Stone P., Richards M., A'Hern R., et al. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11 (2000) 561-567
36. Stone P., Richards M., A'Hern R., et al. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage 22 (2001) 1007-1015
37. Servaes P., Prins S., Verhagen S., et al. Fatigue after breast cancer and in chronic fatigue syndrome: similarities and differences. J Psychosom Res 52 (2002) 453-459
38. Bruera E., Brenneis C., Paterson A.H., et al. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage 4 (1989) 3-6
39. Weitzner M.A., Meyers C.A., and Valentine A.D. Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. Clin Neurosci 7 (1995) 347-350
40. Meyers C.A., Weitzner M.A., Valentine A.D., et al. Methylphenidate therapy improves cognition, mood, and function in brain tumor patients. J Clin Oncol 16 (1998) 2522-2527
41. Breitbart W., and Mermelstein H. An alternative psychostimulant for the management of depressive disorders in cancer patients. Psychosomatics 33 (1992) 352-356
42. Schwartz A.L., Thompson J., and Massood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum 29 (2002) E85-E90
43. Homsi J., Nelson K.A., Sarhill N., et al. A phase II study of methylphenidate for depression in advanced cancer. Am J Hospice Palliative Care 18 (2001) 403-407
44. Sugawara Y., Akechi T., Shima Y., et al. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med 16 (2002) 261-263
45. Hanna A., Sledge G., Mayer M.L., et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 14 (2006) 210-215
46. Bruera E., Driver L., Barnes E.A., et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21 (2003) 4439-4443
47. Marin R. Apathy: concept, syndrome, neural mechanisms, and treatment. Semin Neuropsych 1 (1996) 304-314
48. Popper C.W. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin North Am 9 (2000) 605-646
49. Duffy J.D. The neural substrates of motivation. Psychiatric Ann 27 (1997) 24-29
50. Moller H., Berzewski H., Eckmann F., et al. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients. Pharmacopsychiatry 26 (1993) 75-78
51. Stuppaeck C.H., Geretsegger C., Whitwirth A.B., et al. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. J Clin Psychopharmacol 14 (1994) 241-246
52. Feighner J., Cohn J., Fabre L., et al. A study comparing paroxetine, placebo, and imipramine in depressed patients. J Affect Disord 28 (1993) 71-79
53. Graci G. Pathogenesis and management of cancer-related insomnia. J Support Oncol 3 (2005) 349-359
54. O'Donnell J.F. Insomnia in cancer patients. Clin Cornerstone 6 (2004) S6-S14
55. Holbrook A.M., Crowther R., Lotter A., et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162 (2000) 225-233
56. Schmitz K.H., Holtzman J., Courneya K.S., et al. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 14 (2005) 1588-1595
57. Knols R., Aaronson N.K., Uebelhart D., et al. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 23 (2005) 3830-3842
58. Conn V.S., Hafdahl A., Porock D.C., et al. A meta-analysis of exercise interventions among people treated for cancer. Support Care Cancer 14 (2006) 699-712
59. Jacobsen P.B., Meade C.D., Stein K.D., et al. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol 20 (2002) 2851-2862
60. Mock V. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr 32 (2004) 112-118
61. Galvao D.A., and Newton R.U. Review of exercise interventions studies in cancer patients. J Clin Oncol 23 (2005) 899-909
62. Segar M.L., Katch V.L., Roth R.S., et al. The effect of aerobic exercise on self-esteem and depressive and anxious symptoms among breast cancer survivors. Oncol Nurs Forum 25 (1998) 107-113
63. Jacobsen P.B., Donovan K.A., and Swaine Z.N. Management of Anxiety and Depression in Adult Cancer Patients: Toward an Evidence-Based Approach (2005), Springer-Verlag, New York, NY
64. Barsevick A.M., Sweeney C., Haney E., et al. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncol Nurs Forum 29 (2002) 73-84
65. Murtagh D.R.R., and Greenwood K.M. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 63 (1995) 79-89
66. Cannici J., Malcolm R., and Peek L.A. Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry 14 (1983) 251-256
67. Stam H.J., and Bultz B.D. The treatment of severe insomnia in a cancer patient. J Behav Ther Exp Psychiatry 17 (1986) 33-37
68. Simeit R., Deck R., and Conta-Marx B. Sleep management training for cancer patients with insomnia. Support Care Cancer 12 (2004) 176-183
69. Davidson J.R., Waisberg J.L., Brundage M.D., et al. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncol 10 (2001) 389-397
70. Quesnel C., Savard J., Simard S., et al. Efficacy of cognitive-behavioral therapy for nonmetastatic breast cancer. J Consult Clin Psychol 71 (2003) 189-200